DE69716062D1 - Benzofuran-derivate und deren verwendung - Google Patents
Benzofuran-derivate und deren verwendungInfo
- Publication number
- DE69716062D1 DE69716062D1 DE69716062T DE69716062T DE69716062D1 DE 69716062 D1 DE69716062 D1 DE 69716062D1 DE 69716062 T DE69716062 T DE 69716062T DE 69716062 T DE69716062 T DE 69716062T DE 69716062 D1 DE69716062 D1 DE 69716062D1
- Authority
- DE
- Germany
- Prior art keywords
- benzofurane derivatives
- benzofurane
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96106990 | 1996-05-03 | ||
PCT/EP1997/002092 WO1997042183A1 (en) | 1996-05-03 | 1997-04-24 | Benzofuryl derivatives and their use |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69716062D1 true DE69716062D1 (de) | 2002-11-07 |
DE69716062T2 DE69716062T2 (de) | 2003-06-18 |
Family
ID=8222741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69716062T Expired - Fee Related DE69716062T2 (de) | 1996-05-03 | 1997-04-24 | Benzofuran-derivate und deren verwendung |
Country Status (21)
Country | Link |
---|---|
US (1) | US5955495A (de) |
EP (1) | EP0906301B1 (de) |
JP (1) | JP3148253B2 (de) |
KR (1) | KR100343060B1 (de) |
CN (1) | CN100347164C (de) |
AR (1) | AR006915A1 (de) |
AT (1) | ATE225342T1 (de) |
AU (1) | AU712056B2 (de) |
BR (1) | BR9708902A (de) |
CA (1) | CA2253547C (de) |
CO (1) | CO4940471A1 (de) |
DE (1) | DE69716062T2 (de) |
DK (1) | DK0906301T3 (de) |
ES (1) | ES2182070T3 (de) |
HR (1) | HRP970225A2 (de) |
MA (1) | MA24168A1 (de) |
PE (1) | PE64698A1 (de) |
PT (1) | PT906301E (de) |
TR (1) | TR199802206T2 (de) |
WO (1) | WO1997042183A1 (de) |
ZA (1) | ZA973708B (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2786184B1 (fr) * | 1998-11-24 | 2002-09-20 | Hoechst Marion Roussel Inc | Nouveaux derives du benzofurane, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
JP2005506280A (ja) | 2000-12-20 | 2005-03-03 | ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー | アリールおよびアミノアリール置換セロトニン受容体アゴニストおよびアンタゴニストリガンド |
FR2822463B1 (fr) | 2001-03-21 | 2004-07-30 | Lipha | Derives bicycliques de guanidines et leurs applications en therapeutique |
WO2003082275A1 (en) * | 2002-03-29 | 2003-10-09 | Orion Corporation | Treatment of dependence and dependence related withdrawal symptoms |
FR2845992B1 (fr) * | 2002-10-16 | 2005-02-04 | Pf Medicament | Derives de 3-(cyclopenten-1yl)-benzyl-ou3-(cyclopenten-1yl)- heteroarylmethyl-amines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie |
DE10257357A1 (de) * | 2002-12-09 | 2004-06-24 | Bayer Ag | Fluorhaltige Benzaldehyde |
US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US20050215644A1 (en) * | 2004-03-19 | 2005-09-29 | Interhealth Nutraceuticals, Inc. | Methods for increasing neurotransmitter levels using hydroxycitric acid |
EP2400300A1 (de) | 2004-08-25 | 2011-12-28 | Takeda Pharmaceutical Company Limited | Screeningverfahren von Mitteln zur Prävention/Behandlung von stressbedingter Harninkontinenz |
KR101562549B1 (ko) | 2005-05-10 | 2015-10-23 | 인사이트 홀딩스 코포레이션 | 인돌아민 2,3-디옥시게나제의 조절제 및 이의 사용방법 |
TWI382974B (zh) | 2005-12-20 | 2013-01-21 | Incyte Corp | 作為吲哚胺2,3-二氧化酶調節劑之n-羥基甲脒基雜環化物 |
WO2007132841A1 (ja) | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物およびその用途 |
US20080125470A1 (en) | 2006-09-19 | 2008-05-29 | Incyte Corporation | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
CL2007002650A1 (es) | 2006-09-19 | 2008-02-08 | Incyte Corp | Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras. |
JP5354741B2 (ja) * | 2007-05-29 | 2013-11-27 | 公益財団法人大阪バイオサイエンス研究所 | 睡眠改善剤 |
WO2009063992A1 (ja) | 2007-11-15 | 2009-05-22 | Takeda Pharmaceutical Company Limited | 縮合ピリジン誘導体およびその用途 |
PE20110308A1 (es) | 2008-07-08 | 2011-06-10 | Incyte Corp | 1,2,5-oxadiazoles como inhibidores de indolamina 2,3-dioxigenasa |
UY32940A (es) | 2009-10-27 | 2011-05-31 | Bayer Cropscience Ag | Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas |
JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
CN104045631A (zh) * | 2013-03-13 | 2014-09-17 | 无锡万全医药技术有限公司 | 一种制备5-(4-(4-(5-氰基-1h-吲哚-3-基)丁基)哌嗪-1-基)苯并呋喃-2-甲酰胺的新方法 |
CN103360374B (zh) * | 2013-07-12 | 2016-03-09 | 苏州永健生物医药有限公司 | 维拉唑酮及其盐的合成方法 |
EP3066085B1 (de) | 2013-11-08 | 2020-05-13 | Incyte Holdings Corporation | Verfahren zur herstellung eines indolamin-2,3-dioxygenase-inhibitors |
JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
CN114315773B (zh) * | 2020-09-29 | 2024-01-16 | 广东东阳光药业股份有限公司 | 一种哌嗪化合物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2051986T3 (es) * | 1988-07-05 | 1994-07-01 | Akzo Nv | Compuestos con actividad broncodilatadora. |
US5026726A (en) * | 1989-12-11 | 1991-06-25 | The University Of New Mexico | Gossylic iminolactones and gossylic lactones and their anti-viral activities |
-
1997
- 1997-04-14 US US08/837,140 patent/US5955495A/en not_active Expired - Fee Related
- 1997-04-24 WO PCT/EP1997/002092 patent/WO1997042183A1/en active IP Right Grant
- 1997-04-24 CN CNB971943575A patent/CN100347164C/zh not_active Expired - Fee Related
- 1997-04-24 CA CA002253547A patent/CA2253547C/en not_active Expired - Fee Related
- 1997-04-24 JP JP53947997A patent/JP3148253B2/ja not_active Expired - Fee Related
- 1997-04-24 DK DK97921737T patent/DK0906301T3/da active
- 1997-04-24 BR BR9708902A patent/BR9708902A/pt not_active IP Right Cessation
- 1997-04-24 TR TR1998/02206T patent/TR199802206T2/xx unknown
- 1997-04-24 DE DE69716062T patent/DE69716062T2/de not_active Expired - Fee Related
- 1997-04-24 ES ES97921737T patent/ES2182070T3/es not_active Expired - Lifetime
- 1997-04-24 PT PT97921737T patent/PT906301E/pt unknown
- 1997-04-24 AT AT97921737T patent/ATE225342T1/de not_active IP Right Cessation
- 1997-04-24 AU AU27696/97A patent/AU712056B2/en not_active Ceased
- 1997-04-24 EP EP97921737A patent/EP0906301B1/de not_active Expired - Lifetime
- 1997-04-24 KR KR1019980708809A patent/KR100343060B1/ko not_active IP Right Cessation
- 1997-04-29 ZA ZA9703708A patent/ZA973708B/xx unknown
- 1997-04-30 AR ARP970101780A patent/AR006915A1/es not_active Application Discontinuation
- 1997-04-30 CO CO97023102A patent/CO4940471A1/es unknown
- 1997-04-30 PE PE1997000334A patent/PE64698A1/es not_active Application Discontinuation
- 1997-05-02 MA MA24589A patent/MA24168A1/fr unknown
- 1997-05-02 HR HR96106990.3A patent/HRP970225A2/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1217720A (zh) | 1999-05-26 |
MA24168A1 (fr) | 1997-12-31 |
WO1997042183A1 (en) | 1997-11-13 |
DK0906301T3 (da) | 2003-02-10 |
CO4940471A1 (es) | 2000-07-24 |
HRP970225A2 (en) | 1998-04-30 |
EP0906301A1 (de) | 1999-04-07 |
BR9708902A (pt) | 1999-08-03 |
US5955495A (en) | 1999-09-21 |
DE69716062T2 (de) | 2003-06-18 |
EP0906301B1 (de) | 2002-10-02 |
ZA973708B (en) | 1997-11-03 |
JP3148253B2 (ja) | 2001-03-19 |
CA2253547A1 (en) | 1997-11-13 |
ES2182070T3 (es) | 2003-03-01 |
TR199802206T2 (xx) | 2001-12-21 |
AU2769697A (en) | 1997-11-26 |
AR006915A1 (es) | 1999-09-29 |
CA2253547C (en) | 2006-10-17 |
KR20000010708A (ko) | 2000-02-25 |
ATE225342T1 (de) | 2002-10-15 |
CN100347164C (zh) | 2007-11-07 |
JPH11508283A (ja) | 1999-07-21 |
PT906301E (pt) | 2003-02-28 |
PE64698A1 (es) | 1998-10-27 |
AU712056B2 (en) | 1999-10-28 |
KR100343060B1 (ko) | 2002-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69716062T2 (de) | Benzofuran-derivate und deren verwendung | |
DE69943335D1 (de) | Ionenleitende matrizen und deren verwendung | |
DE69622148D1 (de) | Chinazozin derivate und deren verwendung | |
DE59803292D1 (de) | Triazolverbindungen und deren verwendung als dopamin-d 3-liganden | |
DE873126T1 (de) | Markierte vitamin d-verbindungen und deren verwendung | |
DE69617236D1 (de) | N-heteroaryl-pyridinsulfonamidderivate und deren verwendung als endothelinantagonisten | |
DE59711847D1 (de) | Substituierte aza- und diazacycloheptan- und -cyclooctanverbindungen und deren verwendung | |
DE69738197D1 (de) | Azolotriazine und pyrimidine | |
DE69911378D1 (de) | Fluorierte ionomere und verwendung davon | |
DE69736994D1 (de) | Ionische Malonsäuredinitril Derivate und deren Verwendung | |
FR11C0020I2 (fr) | Dérives difluoroprostaglandines et leur application | |
DE59802439D1 (de) | Spiroverbindungen und deren verwendung | |
DE59506234D1 (de) | Pigmentzubereitung und deren Verwendung | |
DE69123915D1 (de) | Indol-Verbindungen und deren Verwendung | |
DE69729570D1 (de) | Fotpempfindliche zusammensetzung und deren verwendung | |
DE69915066D1 (de) | Biozide zusammensetzung und deren verwendung | |
DE69513307D1 (de) | Zusammensetzung und verwendung | |
DE69713512D1 (de) | Substituierte phtalocyanine und deren verwendung | |
DE69504570D1 (de) | Aufzeichnungsblatt und Aufzeichnung | |
DE69835007D1 (de) | Entkoffeinierte mate-extrakte und deren verwendung | |
DE59810405D1 (de) | Spiroverbindungen und deren verwendung | |
FI964267A (fi) | Porfosyaniini ja CNC-laajennetut porfyriinit | |
DE69620914D1 (de) | Perfluoralkoxycycloalkancarbonylfluorid-zusammensetzungen und ihre verwendung | |
DE69600829D1 (de) | Mikrobizide Zusammensetzung und deren Verwendung | |
DE59508820D1 (de) | Elektrolumineszierende Anordnungen und deren Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |